In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Behind Scios-J&J: No Groundswell for M&A

Executive Summary

While the investment banking world does its best to sing the virtues and likelihood of biotech consolidation, the industry isn't paying attention. Indeed, perhaps the most interesting aspect of J&J's acquisition of Scios isn't the fact that J&J outbid the competition, but just how little competition it had to outbid for one of the very few clearly successful product-oriented biotechs.
Advertisement

Related Content

Reviewing Five Years of Big Pharma's Biotech Acquisitions
Reviewing Five Years of Big Pharma's Biotech Acquisitions
Deal Statistics Quarterly, Q1 2003
Viewing Risk Through a Medicines Co. Lens
Viewing Risk Through a Medicines Co. Lens
Deal Statistics Quarterly, Q1 2003
Enzon and NPS: One Brings the Bread, the Other Brings Wine
Enzon and NPS: One Brings the Bread, the Other Brings Wine

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel